Headlines
-
NHS patients will be among the first in the world to be offered access to the CAR-T therapy.
-
The numbers could be higher as transmission to the wider home community and the journey home were not included in the analysis.
-
The study showed that WBMRI changed how patients would have been managed in 24 per cent of cases, where clinical data alone would have resulted in surveillance only.
